Global Acute Myeloid Leukemia Diagnostics Market - Industry Trends and Forecast to 2031
Description
Global Acute Myeloid Leukemia Diagnostics Market - Industry Trends and Forecast to 2031
Global acute myeloid leukemia diagnostics market is projected to register a substantial CAGR of 11.3% in the forecast period of 2024 to 2031. The new market report contains data for the historic year 2022, the base year of calculation is 2022, and the forecast period is 2024 to 2031.
Market Segmentation
Global Acute Myeloid Leukemia Diagnostics Market, By Product Type (Instruments, and Consumables & Accessories), Test Type (Imaging Test, Blood Test, Bone Marrow Test, Biomarker Test, Immunophenotyping, Genetic Testing and Others), Cancer Type (Myeloblastic (M0), Myeloblastic (M1), Myeloblastic (M2), Promyelocytic (M3), Myelomonocytic (M4), MONOCYTIC (M5), Erythroleukemia (M6) and Megakaryocytic (M7)), Age Group (Below 21, 21-29, 30-65, 65, and Above), Gender (Male and Female) End User (Hospital, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, and Others), Distribution Channel (Direct Tender, Retail Sales), Country ( U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest Of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa) - Industry Trends and Forecast to 2031
Driver
• Increasing diagnostic products for leukemia cancer
Restrain
• Late diagnosis and Poor prognosis of leukemia
Opportunity
• Initiatives by government and other authorities for life sciences and funding
Market Players
Some of the major market players in the global acute myeloid leukemia diagnostics market are:
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific, Inc.
• QIAGEN
• Abbott
• Siemens Healthcare GmbH
• Hologic, Inc.
• Agilent Technologies, Inc.
• DiaSorin S.p.A.
• Illumina, Inc.
• BIOMÉRIEUX
• Myriad Genetics, Inc.
• Quest Diagnostics Incorporated.
• Bio-Rad Laboratories, Inc.
• Koninklijke Philips N.V.
• BD
• Exact Sciences Corporation
• Time Medical Holding
• PlexBio
• MinFound Medical Systems Co., Ltd
• Medonica Co. LTD
• CANON MEDICAL SYSTEMS CORPORATION
• Sysmex Corporation
• Epigenomics AG
• Sonic Healthcare
• SternMed GmbH
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Table of Contents
406 Pages
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of The Global Acute Myeloid Leukemia Diagnostics Market
- 1.4 Limitations
- 1.5 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Dbmr Tripod Data Validation Model
- 2.6 Multivariate Modelling
- 2.7 Product Type Lifeline Curve
- 2.8 Primary Interviews With Key Opinion Leaders
- 2.9 Dbmr Market Position Grid
- 2.10 Market End User Coverage Grid
- 2.11 Vendor Share Analysis
- 2.12 Secondary Sources
- 2.13 Assumptions
- 3 Executive Summary
- 4 Premium Insights
- 4.1 Pestel Analysis
- 4.2 Porter’s Five Forces
- 4.3 Epidemiology
- 5 Global Acute Myeloid Leukemia Diagnostics Market, Regulations
- 5.1 Regulatory Scenario In The U.S.
- 5.2 Regulatory Scenario In Australia
- 5.3 Regulatory Scenario In Japan
- 5.4 Regulatory Scenario In China
- 6 Market Overview
- 6.1 Drivers
- 6.1.1 Growing Prevalence Of Leukemia Cancer
- 6.1.2 Novel Technological Advancements In Leukemia Diagnostics
- 6.1.3 Rising Preference For Preventive Health Check-ups
- 6.1.4 Increase In Awareness Regarding Leukemia Cancer
- 6.2 Restraints
- 6.2.1 Strict Regulations And Standards For The Approval And Commercialization Of Leukemia Diagnostic Products
- 6.2.2 Late Diagnosis And Poor Prognosis Of Leukemia
- 6.3 Opportunities
- 6.3.1 Increase In Diagnostic Products For Leukemia
- 6.3.2 Rise In Healthcare Expenditure For Cancer Diagnosis And Treatment
- 6.3.3 Government Initiatives Toward Cancer Diagnostics
- 6.4 Challenges
- 6.4.1 Increased Cost, Safety, And Convenience Issues
- 6.4.2 Lack Of Skilled And Certified Professionals
- 7 Global Acute Myeloid Leukemia Diagnostics Market, By Product Type
- 7.1 Overview
- 7.2 Instruments
- 7.2.1 Biopsy Instruments
- 7.2.1.1 Bone Marrow Biopsy
- 7.2.1.2 Needle Biopsy
- 7.2.1.3 Surgical Biopsy
- 7.2.1.4 Others
- 7.2.2 Pathology-based Instruments
- 7.2.2.1 Pcr Instruments
- 7.2.2.2 Slide Staining Systems
- 7.2.2.3 Tissue Processing Systems
- 7.2.2.4 Cell Processors
- 7.2.2.5 Other Pathology-based Instruments
- 7.2.3 Imaging Instruments
- 7.2.3.1 Ultrasound Systems
- 7.2.3.2 Ct Systems
- 7.2.3.3 Mri Systems
- 7.2.3.4 Others
- 7.2.4 Others
- 7.3 Consumables & Accessories
- 7.3.1 Kits
- 7.3.1.1 Pcr Kits
- 7.3.1.2 Dna Polymerase Kits
- 7.3.1.3 Nucleic Acid Isolation Kits
- 7.3.1.4 Others
- 7.3.2 Reagents
- 7.3.2.1 Assays
- 7.3.2.2 Buffers
- 7.3.2.3 Primers
- 7.3.2.4 Others
- 7.3.3 Probes
- 7.3.4 Other Consumables
- 8 Global Acute Myeloid Leukemia Diagnostics Market, By Test Type
- 8.1 Overview
- 8.2 Blood Test
- 8.2.1 Complete Blood Count (Cbc)
- 8.2.2 Blood Chemistry Tests
- 8.2.3 Others
- 8.3 Imaging Test
- 8.3.1 Computed Tomography (Ct) Scan
- 8.3.2 Mri
- 8.3.3 Positron Emission Tomography (Pet) Scan
- 8.3.4 Others
- 8.4 Bone Marrow Tests
- 8.4.1 Bone Marrow Aspirate
- 8.4.2 Bone Marrow Biopsy
- 8.4.3 Others
- 8.5 Genetic Tests
- 8.5.1 Fluorescence In Situ Hybridization (Fish)
- 8.5.2 Karyotyping
- 8.5.3 Others
- 8.6 Biomarker Test
- 8.6.1 Genetic Acute Myeloid Leukemia (Aml) Biomarker
- 8.6.2 Epigenetic Acute Myeloid Leukemia (Aml) Biomarker
- 8.6.3 Proteomic Acute Myeloid Leukemia (Aml) Biomarker
- 8.7 Immunophenotyping
- 8.7.1 Flow Cytometry
- 8.7.2 Immunohistochemistry
- 8.7.3 Others
- 8.8 Others
- 9 Global Acute Myeloid Leukemia Diagnostics Market, By Cancer Type
- 9.1 Overview
- 9.2 Myeloblastic (M0)
- 9.3 Myeloblastic (M1)
- 9.4 Myeloblastic (M2)
- 9.5 Promyelocytic (M3)
- 9.6 Myelomonocytic (M4)
- 9.7 Monocytic (M5)
- 9.8 Erythroleukemia (M6)
- 9.9 Megakaryocytic (M7)
- 10 Global Acute Myeloid Leukemia Diagnostics Market, By Age Group
- 10.1 Overview
- 10.2 65 And Above
- 10.3 30-65
- 10.4 Below 21
- 10.5 21-29
- 11 Global Acute Myeloid Leukemia Diagnostics Market, By Gender
- 11.1 Overview
- 11.2 Male
- 11.3 Female
- 12 Global Acute Myeloid Leukemia Diagnostics Market, By End User
- 12.1 Overview
- 12.2 Hospitals
- 12.3 Associated Labs
- 12.4 Independent Diagnostic Laboratories
- 12.5 Diagnostic Imaging Centers
- 12.6 Cancer Research Institutes
- 12.7 Others
- 13 Global Acute Myeloid Leukemia Diagnostics Market, By Distribution Channel
- 13.1 Overview
- 13.2 Direct Tender
- 13.3 Retail Sales
- 14 Global Acute Myeloid Leukemia Diagnostics Market, By Region
- 14.1 Overview
- 14.2 North America
- 14.2.1 U.S.
- 14.2.2 Canada
- 14.2.3 Mexico
- 14.3 Europe
- 14.3.1 Germany
- 14.3.2 United Kingdom
- 14.3.3 France
- 14.3.4 Italy
- 14.3.5 Spain
- 14.3.6 Russia
- 14.3.7 Netherlands
- 14.3.8 Switzerland
- 14.3.9 Belgium
- 14.3.10 Turkey
- 14.3.11 Rest Of Europe
- 14.4 Asia-pacific
- 14.4.1 China
- 14.4.2 Japan
- 14.4.3 India
- 14.4.4 Australia
- 14.4.5 South Korea
- 14.4.6 Indonesia
- 14.4.7 Philippines
- 14.4.8 Thailand
- 14.4.9 Malaysia
- 14.4.10 Vietnam
- 14.4.11 Singapore
- 14.4.12 Rest Of Asia-pacific
- 14.5 South America
- 14.5.1 Brazil
- 14.5.2 Argentina
- 14.5.3 Rest Of South America
- 14.6 Middle East And Africa
- 14.6.1 South Africa
- 14.6.2 Saudi Arabia
- 14.6.3 U.A.E
- 14.6.4 Egypt
- 14.6.5 Israel
- 14.6.6 Rest Of Middle East And Africa
- 15 Global Acute Myeloid Leukemia Diagnostics Market: Company Landscape
- 15.1 Company Share Analysis: Global
- 15.2 Company Share Analysis: North America
- 15.3 Company Share Analysis: Europe
- 15.4 Company Share Analysis: Asia-pacific
- 16 Swot Analysis
- 17 Company Profiles
- 17.1 Canon Medical Systems Corporation.
- 17.1.1 Company Snapshot
- 17.1.2 Revenue Analysis
- 17.1.3 Company Share Analysis
- 17.1.4 Product Portfolio
- 17.1.5 Recent Development
- 17.2 Sysmex Corporation
- 17.2.1 Company Snapshot
- 17.2.2 Revenue Analysis
- 17.2.3 Company Share Analysis
- 17.2.4 Product Portfolio
- 17.2.5 Recent Development
- 17.3 Epigenomics Ag.
- 17.3.1 Company Snapshot
- 17.3.2 Revenue Analysis
- 17.3.3 Company Share Analysis
- 17.3.4 Product Portfolio
- 17.3.5 Recent Development
- 17.4 Myriad Genetics, Inc.
- 17.4.1 Company Snapshot
- 17.4.2 Revenue Analysis
- 17.4.3 Company Share Analysis
- 17.4.4 Product Portfolio
- 17.4.5 Recent Development
- 17.5 F. Hoffmann- La Roche Ltd
- 17.5.1 Company Snapshot
- 17.5.2 Revenue Analysis
- 17.5.3 Company Share Analysis
- 17.5.4 Product Portfolio
- 17.5.5 Recent Development
- 17.6 Abbott
- 17.6.1 Company Snapshot
- 17.6.2 Revenue Analysis
- 17.6.3 Product Portfolio
- 17.6.4 Recent Development
- 17.7 Agilent Technologies, Inc.
- 17.7.1 Company Snapshot
- 17.7.2 Revenue Analysis
- 17.7.3 Product Portfolio
- 17.7.4 Recent Development
- 17.8 Bd
- 17.8.1 Company Snapshot
- 17.8.2 Revenue Analysis
- 17.8.3 Product Portfolio
- 17.8.4 Recent Development
- 17.9 Biomerieux
- 17.9.1 Company Snapshot
- 17.9.2 Product Portfolio
- 17.9.3 Recent Development
- 17.10 Bio-rad Laboratories, Inc.
- 17.10.1 Company Snapshot
- 17.10.2 Revenue Analysis
- 17.10.3 Product Portfolio
- 17.10.4 Recent Development
- 17.11 Diasorin S.P.A.
- 17.11.1 Company Snapshot
- 17.11.2 Revenue Analysis
- 17.11.3 Product Portfolio
- 17.11.4 Recent Developments
- 17.12 Exact Sciences Corporation
- 17.12.1 Company Snapshot
- 17.12.2 Revenue Analysis
- 17.12.3 Product Portfolio
- 17.12.4 Recent Developments
- 17.13 Hologic Inc.
- 17.13.1 Company Snapshot
- 17.13.2 Revenue Analysis
- 17.13.3 Product Portfolio
- 17.13.4 Recent Development
- 17.14 Illumina, Inc.
- 17.14.1 Company Snapshot
- 17.14.2 Revenue Analysis
- 17.14.3 Product Portfolio
- 17.14.4 Recent Development
- 17.15 Koninklijke Philips N.V.
- 17.15.1 Company Snapshot
- 17.15.2 Revenue Analysis
- 17.15.3 Product Portfolio
- 17.15.4 Recent Development
- 17.16 Medonica Co. Ltd
- 17.16.1 Company Snapshot
- 17.16.2 Product Portfolio
- 17.16.3 Recent Development
- 17.17 Minfound Medical Systems Co., Ltd
- 17.17.1 Company Snapshot
- 17.17.2 Product Portfolio
- 17.17.3 Recent Development
- 17.18 Plexbio
- 17.18.1 Company Snapshot
- 17.18.2 Product Portfolio
- 17.18.3 Recent Developments
- 17.19 Qiagen
- 17.19.1 Company Snapshot
- 17.19.2 Revenue Analysis
- 17.19.3 Product Portfolio
- 17.19.4 Recent Developments
- 17.20 Quest Diagnostics Incorporated
- 17.20.1 Company Snapshot
- 17.20.2 Revenue Analysis
- 17.20.3 Product Portfolio
- 17.20.4 Recent Developments
- 17.21 Siemens Healthcare Gmbh
- 17.21.1 Company Snapshot
- 17.21.2 Revenue Analysis
- 17.21.3 Product Portfolio
- 17.21.4 Recent Development
- 17.22 Sonic Healthcare
- 17.22.1 Company Snapshot
- 17.22.2 Product Portfolio
- 17.22.3 Recent Development
- 17.23 Sternmed Gmbh
- 17.23.1 Company Snapshot
- 17.23.2 Product Portfolio
- 17.23.3 Recent Developments
- 17.24 Thermo Fisher Scientific Inc.
- 17.24.1 Company Snapshot
- 17.24.2 Revenue Analysis
- 17.24.3 Product Portfolio
- 17.24.4 Recent Development
- 17.25 Time Medical Holding
- 17.25.1 Company Snapshot
- 17.25.2 Product Portfolio
- 17.25.3 Recent Development
- 18 Questionnaire
- 19 Related Reports
- List Of Tables
- Table 1 Approved Diagnostics Of Leukemia
- Table 2 Global Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 3 Global Instruments In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 4 Global Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 5 Global Biopsy Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 6 Global Pathology-based Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 7 Global Imaging Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 8 Global Consumables & Accessories In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 9 Global Consumables & Accessories In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 10 Global Kits In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 11 Global Reagents In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 12 Global Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 13 Global Blood Test In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 14 Global Blood Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 15 Global Imaging Test In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 16 Global Imaging Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 17 Global Bone Marrow Tests In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 18 Global Bone Marrow Tests In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 19 Global Genetic Tests In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 20 Global Genetic Tests In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 21 Global Biomarker Test In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 22 Global Biomarker Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 23 Global Immunophenotyping In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 24 Global Immunophenotyping In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 25 Global Others In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 26 Global Acute Myeloid Leukemia Diagnostics Market, By Cancer Type, 2022-2031 (Usd Million)
- Table 27 Global Myeloblastic (M0) In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 28 Global Myeloblastic (M1) In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 29 Global Myeloblastic (M2) In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 30 Global Promyelocytic (M3) In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 31 Global Myelomonocytic (M4) In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 32 Global Monocytic (M5) In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 33 Global Erythroleukemia (M6) In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 34 Global Megakaryocytic (M7) Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 35 Global Acute Myeloid Leukemia Diagnostics Market, By Age Group, 2022-2031 (Usd Million)
- Table 36 Global 65 And Above In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 37 Global 30-65 In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 38 Global Below 21 In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 39 Global 21-29 In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 40 Global Acute Myeloid Leukemia Diagnostics Market, By Gender, 2022-2031 (Usd Million)
- Table 41 Global Male In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 42 Global Female In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 43 Global Acute Myeloid Leukemia Diagnostics Market, By End User, 2022-2031 (Usd Million)
- Table 44 Global Hospitals In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 45 Global Associated Labs In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 46 Global Independent Diagnostic Laboratories In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 47 Global Diagnostic Imaging Centers In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 48 Global Cancer Research Institutes In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 49 Global Others In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 50 Global Acute Myeloid Leukemia Diagnostics Market, By Distribution Channel, 2022-2031 (Usd Million)
- Table 51 Global Direct Tender In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 52 Global Retail Sales In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 53 Global Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 54 North America Acute Myeloid Leukemia Diagnostics Market, By Country, 2022-2031 (Usd Million)
- Table 55 North America Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 56 North America Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 57 North America Biopsy Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 58 North America Pathology-based Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 59 North America Imaging Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 60 North America Consumables & Accessories In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 61 North America Kits In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 62 North America Reagents In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 63 North America Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 64 North America Blood Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 65 North America Imaging Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 66 North America Bone Marrow Tests In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 67 North America Genetic Tests In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 68 North America Biomarker Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 69 North America Immunophenotyping In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 70 North America Acute Myeloid Leukemia Diagnostics Market, By Cancer Type, 2022-2031 (Usd Million)
- Table 71 North America Acute Myeloid Leukemia Diagnostics Market, By Age Group, 2022-2031 (Usd Million)
- Table 72 North America Acute Myeloid Leukemia Diagnostics Market, By Gender, 2022-2031 (Usd Million)
- Table 73 North America Acute Myeloid Leukemia Diagnostics Market, By End User, 2022-2031 (Usd Million)
- Table 74 North America Acute Myeloid Leukemia Diagnostics Market, By Distribution Channel, 2022-2031 (Usd Million)
- Table 75 U.S. Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 76 U.S. Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 77 U.S. Biopsy Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 78 U.S. Pathology-based Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 79 U.S. Imaging Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 80 U.S. Consumables & Accessories In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 81 U.S. Kits In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 82 U.S. Reagents In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 83 U.S. Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 84 U.S. Blood Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 85 U.S. Imaging Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 86 U.S. Bone Marrow Tests In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 87 U.S. Genetic Tests In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 88 U.S. Biomarker Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 89 U.S. Immunophenotyping In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 90 U.S. Acute Myeloid Leukemia Diagnostics Market, By Cancer Type, 2022-2031 (Usd Million)
- Table 91 U.S. Acute Myeloid Leukemia Diagnostics Market, By Age Group, 2022-2031 (Usd Million)
- Table 92 U.S. Acute Myeloid Leukemia Diagnostics Market, By Gender, 2022-2031 (Usd Million)
- Table 93 U.S. Acute Myeloid Leukemia Diagnostics Market, By End User, 2022-2031 (Usd Million)
- Table 94 U.S. Acute Myeloid Leukemia Diagnostics Market, By Distribution Channel, 2022-2031 (Usd Million)
- Table 95 Canada Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 96 Canada Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 97 Canada Biopsy Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 98 Canada Pathology-based Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 99 Canada Imaging Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 100 Canada Consumables & Accessories In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 101 Canada Kits In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 102 Canada Reagents In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 103 Canada Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 104 Canada Blood Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 105 Canada Imaging Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 106 Canada Bone Marrow Tests In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 107 Canada Genetic Tests In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 108 Canada Biomarker Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 109 Canada Immunophenotyping In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 110 Canada Acute Myeloid Leukemia Diagnostics Market, By Cancer Type, 2022-2031 (Usd Million)
- Table 111 Canada Acute Myeloid Leukemia Diagnostics Market, By Age Group, 2022-2031 (Usd Million)
- Table 112 Canada Acute Myeloid Leukemia Diagnostics Market, By Gender, 2022-2031 (Usd Million)
- Table 113 Canada Acute Myeloid Leukemia Diagnostics Market, By End User, 2022-2031 (Usd Million)
- Table 114 Canada Acute Myeloid Leukemia Diagnostics Market, By Distribution Channel, 2022-2031 (Usd Million)
- Table 115 Mexico Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 116 Mexico Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 117 Mexico Biopsy Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 118 Mexico Pathology-based Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 119 Mexico Imaging Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 120 Mexico Consumables & Accessories In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 121 Mexico Kits In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 122 Mexico Reagents In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 123 Mexico Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 124 Mexico Blood Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 125 Mexico Imaging Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 126 Mexico Bone Marrow Tests In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 127 Mexico Genetic Tests In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 128 Mexico Biomarker Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 129 Mexico Immunophenotyping In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 130 Mexico Acute Myeloid Leukemia Diagnostics Market, By Cancer Type, 2022-2031 (Usd Million)
- Table 131 Mexico Acute Myeloid Leukemia Diagnostics Market, By Age Group, 2022-2031 (Usd Million)
- Table 132 Mexico Acute Myeloid Leukemia Diagnostics Market, By Gender, 2022-2031 (Usd Million)
- Table 133 Mexico Acute Myeloid Leukemia Diagnostics Market, By End User, 2022-2031 (Usd Million)
- Table 134 Mexico Acute Myeloid Leukemia Diagnostics Market, By Distribution Channel, 2022-2031 (Usd Million)
- Table 135 Europe Acute Myeloid Leukemia Diagnostics Market, By Country, 2022-2031 (Usd Million)
- Table 136 Europe Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 137 Europe Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 138 Europe Biopsy Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 139 Europe Pathology-based Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 140 Europe Imaging Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 141 Europe Consumables & Accessories In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 142 Europe Kits In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 143 Europe Reagents In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 144 Europe Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 145 Europe Blood Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 146 Europe Imaging Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 147 Europe Bone Marrow Tests In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 148 Europe Genetic Tests In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 149 Europe Biomarker Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- List Of Figures
- Figure 1 Global Acute Myeloid Leukemia Diagnostics Market: Segmentation
- Figure 2 Global Acute Myeloid Leukemia Diagnostics Market: Data Triangulation
- Figure 3 Global Acute Myeloid Leukemia Diagnostics Market: Droc Analysis
- Figure 4 Global Acute Myeloid Leukemia Diagnostics Market: Global Vs Regional Market Analysis
- Figure 5 Global Acute Myeloid Leukemia Diagnostics Market: Company Research Analysis
- Figure 6 Global Acute Myeloid Leukemia Diagnostics Market: Interview Demographics
- Figure 7 Global Acute Myeloid Leukemia Diagnostics Market : Dbmr Market Position Grid
- Figure 8 Global Acute Myeloid Leukemia Diagnostics Market: Market End User Coverage Grid
- Figure 9 Global Acute Myeloid Leukemia Diagnostics Market: Vendor Share Analysis
- Figure 10 Global Acute Myeloid Leukemia Diagnostics Market: Segmentation
- Figure 11 The Growing Prevalence Of Leukemia Cancer Is Expected To Drive The Global Acute Myeloid Leukemia Diagnostics Market In The Forecast Period
- Figure 12 The Instruments Segment Is Expected To Account For The Largest Share Of The Global Acute Myeloid Leukemia Diagnostics Market In 2024 & 2031
- Figure 13 North America Is Expected To Dominate The Global Acute Myeloid Leukemia Diagnostics Market And Is Expected To Grow With The Highest Cagr In The Forecast Period
- Figure 14 North America Is The Fastest-growing Market For Global Acute Myeloid Leukemia Diagnostics Market Manufacturers In The Forecast Period
- Figure 15 Drivers, Restraints, Opportunities, And Challenges Of The Global Acute Myeloid Leukemia Diagnostics Market
- Figure 16 Number Of Prevalence Of Leukemia Incidence Worldwide (Both Sexes)
- Figure 17 Five Years Prevalence Leukemia Incidence Worldwide (Both Sexes)
- Figure 18 Global Acute Myeloid Leukemia Diagnostics Market: By Product Type, 2023
- Figure 19 Global Acute Myeloid Leukemia Diagnostics Market: By Product Type, 2024-2031 (Usd Million)
- Figure 20 Global Acute Myeloid Leukemia Diagnostics Market: By Product Type, Cagr (2024-2031)
- Figure 21 Global Acute Myeloid Leukemia Diagnostics Market: By Product Type, Lifeline Curve
- Figure 22 Global Acute Myeloid Leukemia Diagnostics Market: By Test Type, 2023
- Figure 23 Global Acute Myeloid Leukemia Diagnostics Market: By Test Type, 2024-2031 (Usd Million)
- Figure 24 Global Acute Myeloid Leukemia Diagnostics Market: By Test Type, Cagr (2024-2031)
- Figure 25 Global Acute Myeloid Leukemia Diagnostics Market: By Test Type, Lifeline Curve
- Figure 26 Global Acute Myeloid Leukemia Diagnostics Market: By Cancer Type, 2023
- Figure 27 Global Acute Myeloid Leukemia Diagnostics Market: By Cancer Type, 2024-2031 (Usd Million)
- Figure 28 Global Acute Myeloid Leukemia Diagnostics Market: By Cancer Type, Cagr (2024-2031)
- Figure 29 Global Acute Myeloid Leukemia Diagnostics Market: By Cancer Type, Lifeline Curve
- Figure 30 Global Acute Myeloid Leukemia Diagnostics Market: By Age Group, 2023
- Figure 31 Global Acute Myeloid Leukemia Diagnostics Market: By Age Group, 2024-2031 (Usd Million)
- Figure 32 Global Acute Myeloid Leukemia Diagnostics Market: By Age Group, Cagr (2024-2031)
- Figure 33 Global Acute Myeloid Leukemia Diagnostics Market: By Age Group, Lifeline Curve
- Figure 34 Global Acute Myeloid Leukemia Diagnostics Market: By Gender, 2023
- Figure 35 Global Acute Myeloid Leukemia Diagnostics Market: By Gender, 2024-2031 (Usd Million)
- Figure 36 Global Acute Myeloid Leukemia Diagnostics Market: By Gender, Cagr (2024-2031)
- Figure 37 Global Acute Myeloid Leukemia Diagnostics Market: By Gender, Lifeline Curve
- Figure 38 Global Acute Myeloid Leukemia Diagnostics Market: By End User, 2023
- Figure 39 Global Acute Myeloid Leukemia Diagnostics Market: By End User, 2024-2031 (Usd Million)
- Figure 40
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
